- Home
- Products
Products
We believe in the future role of personalized medicine as the best means to improve patient quality of life.
Proteomika's goal is to provide clinical specialists with diagnostic products and services that improve disease diagnosis and that allow the response of patients to treatment to be monitored.
Our products are designed to help the medical community by developing a new generation of diagnostic products bringing benefits in areas that are still unexplored, such as monitoring of patients treated with biological drugs for unwanted side effects of treatment or assessing the receptivity of the endometrium to embryo implantation prior to in vitro fertilization (IVF) procedures.
Proteomika works actively towards the identification of novel biomarkers for non-invasive diagnosis of disease primarily in the areas of oncology and gynecological disease.
Monitoring patients prescribed with anti-TNFα biologic drugs for the treatment of chronic inflammatory disease
A pioneering test to predict endometrial function and receptivity to embryo implantation for women undergoing IVF treatment
A novel tool for epidemiological surveillance of pneumococcal infections